Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms.
about
PKA and CDK5 can phosphorylate specific serines on the intracellular domain of podoplanin (PDPN) to inhibit cell motilityThe chimeric antibody chLpMab-7 targeting human podoplanin suppresses pulmonary metastasis via ADCC and CDC rather than via its neutralizing activity.High expression of podoplanin in squamous cell carcinoma of the tongue occurs predominantly in patients ≤40 years but does not correlate with tumour spread.Podoplanin is a component of extracellular vesicles that reprograms cell-derived exosomal proteins and modulates lymphatic vessel formationDifferences in cardiovascular toxicities associated with cigarette smoking and snuff use revealed using novel zebrafish modelsComponents in aqueous Hibiscus rosa-sinensis flower extract inhibit in vitro melanoma cell growth.Single cell time-lapse analysis reveals that podoplanin enhances cell survival and colony formation capacity of squamous cell carcinoma cells.Zebrafish as a Model Organism for the Development of Drugs for Skin Cancer.Correlation between podoplanin expression and extracapsular spread in squamous cell carcinoma of the oral cavity using subjective immunoreactivity scores and semiquantitative image analysis.Podoplanin Expression in Canine Melanoma.Podoplanin is an important stromal prognostic marker in perihilar cholangiocarcinoma.Podoplanin Expression Is Correlated With the Progression of Chronic Discoid Lupus Erythematosus to Lip Squamous Cell Carcinoma.Podoplanin - an emerging cancer biomarker and therapeutic target.
P2860
Q36015517-60FC4D55-E13A-4896-89AC-B78F021E642BQ36546538-53F10685-74AC-4E55-977E-AFF7067EC113Q36873805-D12DAC2B-6CF0-45D1-94BA-7B0EC8335E31Q37085956-3BBF8395-C515-49FD-B157-EE3713A08C80Q37120314-6B7C2C20-84C6-42F7-9CA9-8CA50F7D101FQ37544079-373873F8-14A4-40CC-A20A-23C9CB476971Q37563539-2AF955E4-2F83-492A-B31D-F7A84520DA26Q38656012-BE7EDA9A-ECBB-4735-9038-4F0F8B0B12E6Q39581199-6E34CC48-3D37-407D-8AD5-92B03CF7CD07Q40546654-D4B4D155-D03F-4776-92AA-BC2EB3B6CB4AQ49267445-ADF589FA-FC01-4BE3-BFAB-24FEC17DAE85Q51729897-7AB808A3-22C6-4D28-8BD2-575772BBDFB3Q52724361-FE31EB81-040F-4520-9955-1ECAC983DFA0
P2860
Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Antibody and lectin target pod ...... bility by distinct mechanisms.
@en
type
label
Antibody and lectin target pod ...... bility by distinct mechanisms.
@en
prefLabel
Antibody and lectin target pod ...... bility by distinct mechanisms.
@en
P2093
P2860
P356
P1433
P1476
Antibody and lectin target pod ...... ability by distinct mechanisms
@en
P2093
Alan J Shienbaum
David Kephart
Edward P Retzbach
Evan Nevel
Evelyne Kalyoussef
Gary S Goldberg
Harini Krishnan
Jhon A Ochoa-Alvarez
John G Pastorino
Joseph J Lee
P2860
P304
P356
10.18632/ONCOTARGET.3515
P407
P577
2015-04-01T00:00:00Z